...
首页> 外文期刊>Advances in Radiation Oncology >Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
【24h】

Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer

机译:简单原始式间质肺异常评分的有用性,用于预测辐射肺炎的辐射肺炎,要求在局部晚期非小细胞肺癌患者的明确放射治疗后进行甾体处理

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PurposeAdjuvant durvalumab has become a standard treatment after chemoradiation therapy for patients with locally advanced non-small cell lung cancer (LA-NSCLC). Accordingly, predicting radiation pneumonitis (RP) requiring steroidal treatment (steroid-RP) is of utmost importance because steroidal administration is reported to weaken the effectiveness of immunotherapy. However, grade 2 RP was used as an index of RP in previous studies, but it is an ambiguous definition because it includes not only steroid-RP but also a mild cough requiring only a cough medicine. Therefore, in this study, steroid-RP was used for evaluating RP, and the purpose of this study was to investigate predictive factors of steroid-RP, including original simple interstitial lung abnormality scores (ILASs).Methods and MaterialsA total of 145 patients with LA-NSCLC who received definitive radiation therapy (DRT) in our institution from January 2014 to May 2017 were identified. Original ILASs, performance status, age, respiratory function, Brinkman index, concurrent administration of chemotherapy, and dose–volume histogram metrics of the lung were analyzed to evaluate their association with steroid-RP. Additionally, 3 diagnostic radiologists evaluated the patients’ pre-DRT chest computed tomography images and determined the simple ILASs. ILASs were rated as follows: 0: none; 1: abnormality without honeycombing (ground-glass attenuation, fine reticular opacity, and microcysts); and 2: honeycombing.ResultsThe median follow-up period was 729 days. Thirty-one patients (21.4%) experienced steroid-RP. In the univariate analysis, lung V5/V10/VS5, Brinkman index, and ILASs were significant predictive factors of steroid-RP. Additionally, multivariate analysis including Brinkman index ≥840, lung V5 ≥37%, and an ILAS ≥1 revealed that only an ILAS (P= .001) was an independent predictive factor of steroid-RP.ConclusionsThe original simple ILAS was an easy-to-use tool and a significant predictive factor of steroid-RP in DRT in patients with LA-NSCLC.
机译:PurposeadJuvant Durvalumab在局部晚期非小细胞肺癌(La-NSClc)的患者中达到了标准治疗方法。因此,预测需要甾体处理(类固醇RP)的辐射肺炎(RP)至关重要,因为据报道甾体局促进免疫疗法的有效性。然而,2级RP被用作先前研究中RP的指标,但它是一种模糊的定义,因为它不仅包括类固醇RP,而且还包括一种温和的咳嗽,需要仅需要咳嗽药。因此,在本研究中,类固醇RP用于评估RP,本研究的目的是调查类固醇RP的预测因素,包括原始简单的间质肺异常分数(ILASS)。方法和材料总共145名患者确定了从2014年1月到2017年5月到2017年5月在我们的机构中​​获得过明确的放射治疗(DRT)的La-NSCLC。分析了原始ILAS,性能状态,年龄,呼吸功能,Brinkman指数,化疗同时施用和肺的剂量血液图测量,评价它们与类固醇RP的关联。此外,3位诊断放射科医生评估了患者的DRT胸部计算断层摄影图像并确定了简单的ILAS。 ilass被评为如下:0:无; 1:没有蜂窝状的异常(磨光玻璃衰减,细网外不透明度和微囊体);和2:蜂窝状。培养中间的后续期间为729天。三十一名患者(21.4%)经验丰富的类固醇RP。在单变量分析中,肺v5 / v10 / vs5,Brinkman指数和Inass是类固醇RP的显着预测因素。另外,包括Brinkman指数≥840,肺v5≥37%,肺活量≥1的多变量分析显示,只有ILAS(p = .001)是甾体rp的独立预测因素.Conclusionsthe原始简单的ILA是一种简单的La-NSCLC患者DRT中甾粒子的使用工具和类固醇RP的显着预测因子。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号